Therma Bright Inc.

Equities

THRM

CA8834261080

Advanced Medical Equipment & Technology

Delayed Toronto S.E. Other stock markets 01:34:08 2024-04-26 pm EDT			5-day change	1st Jan Change
0.01 ^CAD	0.00%		0.00%	-60.00%

Apr. 01	Therma Bright Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	CI
Jan. 10	Therma Bright Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023	CI

Therma Bright Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024

April 01, 2024 at 05:12 pm EDT

Therma Bright Inc. reported earnings results for the second quarter and six months ended January 31, 2024. For the second quarter, the company reported sales was CAD 0.007795 million compared to CAD 0.006543 million a year ago. Net loss was CAD 0.113052 million compared to CAD 0.696285 million a year ago.
For the six months, sales was CAD 0.014382 million compared to CAD 0.012491 million a year ago. Net loss was CAD 0.257219 million compared to CAD 1.15 million a year ago.

Latest news about Therma Bright Inc.

Therma Bright Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	Apr. 01	CI
Therma Bright Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023	Jan. 09	CI
Therma Bright Inc. Reports Earnings Results for the Full Year Ended July 31, 2023	Jan. 04	CI
Ontario Securities Commission Issues Cease Trade Order Against Therma Bright Inc	Dec. 06	CI
Therma Bright Prepares Fda 513(G) Review Therma Bright Prepares FDA 513(G) Review Analyzer	Nov. 29	CI
Therma Bright Inc. Announces Venowave Pilot Tests with Existing and New Distribution Partners in the United States	Nov. 02	CI
Therma Bright Inc. Announces Chief Financial Officer Changes	23-09-29	CI
Therma Bright Inc Signs Hero Lifecare to A U.S. Distribution Partner for Marketing and Selling the Venowave Device	23-09-13	CI
Therma Bright Inc. Submits Updated FDA 510K Application Requesting Correction of Venowave Device's Intended Use, Labeling, and Description	23-09-07	CI
Therma Bright Inc. Provides Update on Venowave for the United States and Texas Region	23-06-30	CI
Therma Bright Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	23-06-28	CI
Therma Bright Inc. and Inretio Inc. Announces Successful Completion of Good Laboratory Practice Study for Its Breakthrough Preva™? Mechanical Thrombectomy Device	23-06-07	CI
Therma Bright Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	23-04-03	CI
Therma Bright Inc. Provides an Update on Its Partnership with Inretio Inc	23-02-23	CI
Therma Bright Inc. Reports Earnings Results for the First Quarter Ended October 31, 2022	22-12-23	CI
Therma Bright Inc. Auditor Raises 'Going Concern' Doubt	22-11-27	CI
Therma Bright Inc. Reports Earnings Results for the Full Year Ended July 31, 2022	22-11-27	CI
Therma Bright Agrees to Buy Exclusive License for Patented Digital Cough-Based Technology to Detect Respiratory Diseases	22-11-17	MT
Therma Bright Receives Payment for Initial Venowave Sales	22-09-20	CI
Therma Bright Inc. Provides Update on FDA EUA Review Process	22-09-12	CI
Therma Bright Inc. Provides Updates on Applications for Its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test	22-08-04	CI
Therma Bright Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022	22-06-29	CI
Therma Bright Submits Health Canada Application for Its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test for Point-of-Care	22-06-23	CI
Therma Bright Provides Update on EUA Application Process For AcuVid COVID-19 Test	22-06-02	MT
Therma Bright Inc. Provides Update on FDA EUA Application Process for Acuvid(TM) Covid-19 Rapid Antigen Saliva Test	22-06-02	CI

Chart Therma Bright Inc.

Duration

Period

More charts

Company Profile

Therma Bright Inc. is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. The Venowave is a medical compression pump that is lightweight, compact, battery operated, designed to treat and alleviate the symptoms associated with poor circulation.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-06-25 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMA BRIGHT INC.	-60.00%	2.31M
THERMO FISHER SCIENTIFIC	+8.56%	219B
DANAHER CORPORATION	+6.45%	183B
INTUITIVE SURGICAL, INC.	+10.86%	133B
BOSTON SCIENTIFIC CORPORATION	+25.25%	108B
SIEMENS HEALTHINEERS AG	+0.27%	63.06B
EDWARDS LIFESCIENCES CORPORATION	+12.59%	52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+3.96%	48.2B
AGILENT TECHNOLOGIES, INC.	+0.33%	40.37B
GE HEALTHCARE TECHNOLOGIES INC.	+15.03%	39.35B

Other Advanced Medical Equipment & Technology